MabThera Receives Positive Opinion in Europe for Combination With Any Chemotherapy Regimen in First-Line Treatment for Follicular Non-Hodgkin's Lymphoma
Basel, Switzerland (ots/PRNewswire) - - Physicians Will be Able to Prescribe MabThera With Their Preferred Chemotherapy Regimen as Initial Treatment Roche announced today that the European Union's Committee on Human Medical Products (CHMP) has given a positive recommendation for extension of the MabThera ...